From signal to alert : A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines

© 2022 Australasian College for Emergency Medicine..

OBJECTIVE: To illustrate the toxicosurveillance role of the Emerging Drugs Network of Australia - Victoria (EDNAV) project in informing timely harm minimisation interventions.

METHODS: Utilisation of an ethics approved clinical registry storing de-identified clinical and analytical data on Victorian ED illicit drug-related presentations.

RESULTS: In April 2022, six adults presented to hospital with varying levels of sedation, following the use of counterfeit benzodiazepines. Comprehensive toxicological analysis identified five separate novel benzodiazepines within blood samples from each patient. A public 'Drug Alert' was subsequently issued, and local emergency physicians were notified.

CONCLUSION: Toxicosurveillance projects, such as EDNAV, are critical to the continued monitoring and reporting of illicit substance use in the community.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Emergency medicine Australasia : EMA - 35(2023), 1 vom: 01. Feb., Seite 165-167

Sprache:

Englisch

Beteiligte Personen:

Syrjanen, Rebekka [VerfasserIn]
Schumann, Jennifer [VerfasserIn]
Hodgson, Sarah E [VerfasserIn]
Abouchedid, Rachelle [VerfasserIn]
Rotella, Joe-Anthony [VerfasserIn]
Graudins, Andis [VerfasserIn]
Greene, Shaun L [VerfasserIn]

Links:

Volltext

Themen:

12794-10-4
Alprazolam
Benzodiazepines
Early warning system
Journal Article
Novel benzodiazepines
Novel psychoactive substances
Tablets
Toxicosurveillance
YU55MQ3IZY

Anmerkungen:

Date Completed 18.01.2023

Date Revised 31.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/1742-6723.14108

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347864058